Questions Ask question Search Order By: ActiveCategoryClear Filter 0 Votes 1 Ans Is an audit of QA activities required? 1.77K viewsDrugsPharmaceutical 0 Votes 1 Ans Who should sign the QA statement? 1.82K viewsDrugsPharmaceutical 0 Votes 1 Ans What should appear on a quality assurance statement? 1.78K viewsDrugsPharmaceutical 0 Votes 1 Ans What standard should be applied to the validation of methods which are used in GLP studies and how should it be applied? 1.85K viewsDrugsPharmaceutical 0 Votes 1 Ans Should method validation be completed prior to the initiation of a GLP study? 1.73K viewsDrugsPharmaceutical 0 Votes 1 Ans Following the early termination of a GLP study is there a requirement to produce a final report? 1.85K viewsDrugsPharmaceutical 0 Votes 1 Ans Under what circumstances can a GLP study be reopened after the final report has been finalised? 1.73K viewsDrugsPharmaceutical 0 Votes 1 Ans Section 2.8 of OECD Advisory Document Number 16 (Guidance on the GLP Requirements for Peer Review of Histopathology) indicates that where the peer reviewing pathologist’s findings were significantly different from the original interpretation of the study pathologist, a description of how differences of interpretation were handled and changes made to the study pathologist’s original interpretation should be discussed in the final report. Does this apply to both retrospective and contemporaneous peer review? 1.69K viewsDrugsPharmaceutical 0 Votes 1 Ans Section 2.5 of OECD Advisory Document Number 16 (Guidance on the GLP Requirements for Peer Review of Histopathology) indicates that all correspondence regarding the histopathological evaluation of the slides used for peer review between the sponsor and the representative of the test facility and the peer reviewing pathologist should be retained in the study file. Could the interpretation of this requirement be clarified? 1.42K viewsDrugsPharmaceutical 0 Votes 1 Ans Do software programmes which have been developed by outside vendors or academia to support calculations by test facilities using an OECD Test Guideline, and are referenced in OECD Test Guidelines, need to be validated by test facilities? 1.79K viewsDrugsPharmaceutical 0 Votes 1 Ans Can GLP studies be done in facilities that utilise other quality standards (GMP, GCP, ISO etc.)? 1.83K viewsDrugsPharmaceutical 0 Votes 1 Ans Is there a standard format and content for the Study Director’s statement? 1.94K viewsDrugsPharmaceutical 0 Votes 1 Ans What is a physical/chemical test system? 1.85K viewsDrugsPharmaceutical 0 Votes 1 Ans How can the GLP compliance status of a test facility or test site be checked? 1.84K viewsDrugsPharmaceutical 0 Votes 1 Ans What are the clinical trial information requirements for voluntary submissions under the regulation? 1.92K viewsFDA 0 Votes 1 Ans What is a “triggered” trial under the regulation? 1.54K viewsFDA 0 Votes 1 Ans When must clinical trial information for a “triggered trial” be submitted to meet the requirements for voluntary submissions under 42 CFR 11.60? 2.09K viewsFDA 0 Votes 1 Ans Why should I participate in medical research? 1.82K viewsFDA 0 Votes 1 Ans What should I expect if I join a research study? 1.70K viewsFDA 0 Votes 1 Ans What is informed consent? 1.84K viewsFDA « Previous 1 2 … 250 251 252 253 254 … 283 284 Next » Question and answer is powered by anspress.net
